Dublin, Oct. 24, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Imaging Agents - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Imaging Agents in US$ by the following Product Segments: Contrast Media (X-Ray/CT, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 53 companies including many key and niche players such as
- Aytu BioScience, Inc. (US)
- Bayer Healthcare Pharmaceuticals (Germany)
- Bracco Diagnostics, Inc. (US)
- Daiichi Sankyo Company Limited (Japan)
- Eisai Co., Ltd. (Japan)
- Eli Lilly and Company (US)
- GE Healthcare (UK)
- Guerbet Group (France)
- Lantheus Medical Imaging, Inc. (US)
- Mallinckrodt plc (Ireland)
Key Topics Covered:
1. Industry Overview
2. Segmental Overview And Competitive Landscape
3. Market Trends & Issues
4. Global Medical Imaging Market - An Overview
5. Product Overview
6. Technology Dynamics
7. Product Launches/Approvals/ Clinical Trials
8. Recent Industry Activity
9. Focus On Select Players
10. Global Market Perspective
Total Companies Profiled: 53 (including Divisions/Subsidiaries 61)
- The United States (33)
- Canada (2)
- Japan (1)
- Europe (19)
- - France (3)
- - Germany (5)
- - The United Kingdom (2)
- - Italy (2)
- - Rest of Europe (7)
- Asia-Pacific (Excluding Japan) (5)
- Africa (1)
For more information about this report visit http://www.researchandmarkets.com/research/2mgfvc/imaging_agents